Therapy of antihistamine-resistant chronic spontaneous urticaria

References

• Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014 May;133(5):1270–1277.
   PubMed Web of Science ®Google Scholar
• Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy. 2011;66:317–330.
   PubMed Web of Science ®Google Scholar
• Sanchez-Borges M, Asero R, Ansotegui IJ, et al. Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J. 2012;5:125–147.
   PubMedGoogle Scholar
• Greaves M. Chronic urticaria. J Allergy Clinical Immunol. 2000;105:664–672.
   PubMed Web of Science ®Google Scholar
• O’Donnell BF, Lawlor F, Simpson J, et al. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997;136:197–201.
   PubMed Web of Science ®Google Scholar
• Grob JJ, Gaudy-Marqueste C. Urticaria and quality of life. Clin Rev Allergy Immunol. 2006;30:47–51.
   PubMed Web of Science ®Google Scholar
• Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009;64:1417.
   PubMed Web of Science ®Google Scholar
• Kaplan AP, Greaves M. Pathogenesis of chronic urticaria. Clin Exp Allergy. 2009;39:777–787.
   PubMed Web of Science ®Google Scholar
• Viswanathan RK, Biagtan MJ, Mathur SK. The role of autoimmune testing in chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2012;108(5):337–341.
   PubMed Web of Science ®Google Scholar
• Toubi E, Kessel A, Avshovich N, et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy. 2004;59(8):869–873.
   PubMed Web of Science ®Google Scholar
• Sabroe RA, Fiebiger E, Francis DM, et al. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol. 2002;110(3):492–499.
   PubMed Web of Science ®Google Scholar
• Viegas LP, Ferreira MB, Kaplan AP. The maddening itch: an approach to chronic urticaria. J Investig Allergol Clin Immunol. 2014;24(1):1–5.
   PubMed Web of Science ®Google Scholar
• Fine LM, Bernstein JA. Guideline of chronic urticaria beyond. Allergy Asthma Immunol Res. 2016 Sep;8(5):396–403.
   PubMed Web of Science ®Google Scholar
• Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2) LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014;69:868–887.
   PubMed Web of Science ®Google Scholar
• Ben-Shoshan B, Blinderman I, Raz A. Psychosocial factors and chronic spontaneous urticaria: a systematic review. Allergy. 2013;68(2):131–141.
   PubMed Web of Science ®Google Scholar
• Yeung H, Swerlick RA. Evidence on pseudoallergen-free diet for chronic urticaria. J Am Acad Dermatol. 2015 Jun;72(6):e181.
   Google Scholar
• Kaplan AP. Treatment of chronic spontaneous urticaria. Allergy Asthma Immunol Res. 2012 Nov;4(6):326–331.
   PubMed Web of Science ®Google Scholar
• Amin P, Levin L, Holmes SJ, et al. Investigation of patient-specific characteristics associated with treatment outcomes for chronic urticaria. J Allergy Clin Immunol Pract. 2015 May–Jun;3(3):400–407.
   PubMed Web of Science ®Google Scholar
• Kozel MM, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs. 2004;64:2515–2536.
   PubMed Web of Science ®Google Scholar
• Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. Ann Allergy Asthma Immunol. 2008;100(5):403–411.
   PubMed Web of Science ®Google Scholar
• Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 2. Ann Allergy Asthma Immunol. 2008;100:517–526.
   PubMed Web of Science ®Google Scholar
• Shekelle PG, Woolf SH, Eccles M, et al. Clinical guidelines: developing guidelines. BMJ. 1999;318:593–596.
   PubMed Web of Science ®Google Scholar
• Morsman CD, Livesey SJ, Richards IM, et al. Screening for hydroxychloroquine retinal toxicity: is it necessary? Eye. 1990;4:572–576.
   PubMed Web of Science ®Google Scholar
• Reeves GE, Boyle MJ, Bonfield J, et al. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J. 2004;34:182.
   PubMed Web of Science ®Google Scholar
• Cassano N, D’Argento V, Filotico R, et al. Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study. Acta Derm Venereol. 2005;85:254.
   PubMed Web of Science ®Google Scholar
• Jaffer AM. Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria. J Allergy Clin Immunol. 1991;88:964–965.
   PubMed Web of Science ®Google Scholar
• Hartmann K, Hani N, Hinrichs R, et al. Successful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticaria. Acta Derm Venereol. 2001;81:71.
   PubMed Web of Science ®Google Scholar
• Engler RJM, Squire E, Benson P. Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema. Ann Allergy Asthma Immunol. 1995;74:155–159.
   PubMed Web of Science ®Google Scholar
• McGirt LY, Vasagar K, Gober LM, et al. Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol. 2006;142:1337–1342.
   PubMedGoogle Scholar
• Orden RA, Timble H, Saini SS. Efficacy and safety of sulfasalazine in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2014;112:64.
   PubMed Web of Science ®Google Scholar
• Lawlor F, Black AK, Ward AM, et al. Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine. Br J Dermatol. 1989;120:403–408.
   PubMed Web of Science ®Google Scholar
• Tharp MD. Chronic urticaria: pathophysiology and treatment approaches. J Allergy Clin Immunol. 1996;98:S325.
   PubMed Web of Science ®Google Scholar
• Criado RF, Criado PR, Martins JE, et al. Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features. J Dermatolog Treat. 2008;19:92.
   PubMed Web of Science ®Google Scholar
• Pho LN, Eliason MJ, Regruto M, et al. Treatment of chronic urticaria with colchicine. J Drugs Dermatol. 2011;10:1423.
   PubMed Web of Science ®Google Scholar
• Powell RJ, Du Toit GL, Siddique N, et al. BSACI guidelines for the management of chronic urticaria and angioedema. Clin Exp Allergy. 2007;37:631.
   PubMed Web of Science ®Google Scholar
• Marsland AM, Beck MH. Cold urticaria responding to systemic ciclosporin. Br J Dermatol. 2003;149:214.
   PubMed Web of Science ®Google Scholar
• Loria MP, Dambra PP, D’Oronzio L, et al. Cyclosporin A in patients affected by chronic idiopathic urticaria: a therapeutic alternative. Immunopharmacol Immunotoxicol. 2001;23:205.
   PubMed Web of Science ®Google Scholar
• Vena GA, Cassano N, Colombo D, et al.; Neo-I-30 Study Group. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol. 2006;55:705–709.
   PubMed Web of Science ®Google Scholar
• Di Leo E, Nettis E, Aloia AM, et al. Cyclosporine-A efficacy in chronic idiopathic urticaria. Int J Immunopathol Pharmacol. 2011;24:195–200.
   PubMed Web of Science ®Google Scholar
• Di Gioacchino M, Di Stefano F, Cavallucci E, et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc. 2003;24:285–290.
   PubMed Web of Science ®Google Scholar
• Grattan CE, O’Donnell B, Francis D, et al. Randomized double-blind study of cyclosporin in chronic “idiopathic” urticaria. Br J Dermatol. 2000;143:365–372.
   PubMed Web of Science ®Google Scholar
• Toubi E, Blant A, Kessel A, et al. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy. 1997;52:312–316.
   PubMed Web of Science ®Google Scholar
• Kessel A, Bamberger E, Toubi E. Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study. J Am Acad Dermatol. 2005;52:145–148.
   PubMed Web of Science ®Google Scholar
• Morgan M. Treatment of refractory chronic urticaria with sirolimus. Arch Dermatol. 2009;145:637.
   PubMedGoogle Scholar
• Shahar E, Bergman R, Guttman-Yassky E, et al. Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids. Int J Dermatol. 2006;45:1224–1227.
   PubMed Web of Science ®Google Scholar
• Zimmerman AB, Berger EM, Elmariah SB, et al. The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients. J Am Acad Dermatol. 2012;66:767.
   PubMed Web of Science ®Google Scholar
• Spector SL, Tan RA. Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol. 2007;99:190–193.
   PubMed Web of Science ®Google Scholar
• Kaplan AP, Joseph K, Maykut RJ, et al. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008;122:569.
   PubMed Web of Science ®Google Scholar
• Spector SL, Tan RA. Therapeutic alternatives for chronic urticaria: additional reports on omalizumab. Ann Allergy Asthma Immunol. 2008;101:647.
   PubMed Web of Science ®Google Scholar
• Güzelbey O, Ardelean E, Magerl M, et al. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy. 2008;63:1563.
   PubMed Web of Science ®Google Scholar
• Romano C, Sellitto A, De Fanis U, et al. Maintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticaria. Ann Allergy Asthma Immunol. 2010;104:95–97.
   PubMed Web of Science ®Google Scholar
• Groffik A, Mitzel-Kaoukhov H, Magerl M, et al. Omalizumab–an effective and safe treatment of therapy-resistant chronic spontaneous urticaria. Allergy. 2011;66:303–305.
   PubMed Web of Science ®Google Scholar
• Metz M, Altrichter S, Ardelean E, et al. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol. 2011;154:177.
   PubMed Web of Science ®Google Scholar
• Ferrer M, Gamboa P, Sanz ML, et al. Omalizumab is effective in nonautoimmune urticaria. J Allergy Clin Immunol. 2011;127:1300.
   PubMed Web of Science ®Google Scholar
• Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol. 2006;117:1415.
   PubMed Web of Science ®Google Scholar
• Saini S, Rosen KE, Hsieh HJ, et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011;128:567–573.
   PubMed Web of Science ®Google Scholar
• Kaplan A. Therapy of chronic urticaria: a simple, modern approach. Ann Allergy Asthma Immunol. 2014 May;112(5):419–425.
   PubMed Web of Science ®Google Scholar
• Maurer M, Altrichter S, Bieber T, et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol. 2011;128:202–209.
   PubMed Web of Science ®Google Scholar
• Maurer M, Rosén K, Hsieh HJ, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013;368:924.
   PubMed Web of Science ®Google Scholar
• Kaplan A, Ledford D, Ashby M, et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013;132:101.
   PubMed Web of Science ®Google Scholar
• Song CH, Stern S, Giruparajah M, et al. Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria. Ann Allergy Asthma Immunol. 2013;110:113–117.
   PubMed Web of Science ®Google Scholar
• Arkwright PD. Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria. J Allergy Clin Immunol. 2009;123(2):510–511.
   PubMed Web of Science ®Google Scholar
• Chakravarty SD, Yee AF, Paget SA. Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies. J Allergy Clin Immunol. 2011;128(6):1354–1355.
   PubMed Web of Science ®Google Scholar
• Bernstein JA, Garramone SM, Lower EG. Successful treatment of autoimmune chronic idiopathic urticarial with intravenous cyclophosphamide. Ann Allergy Asthma Immunol. 2002;89:212–214.
   PubMed Web of Science ®Google Scholar
• Asero R. Oral cyclophosphamide in a case of cyclosporine and steroid-resistant chronic urticaria showing autoreactivity on autologous serum skin testing. Clin Exp Dermatol. 2005;30:582–583.
   PubMed Web of Science ®Google Scholar